COVID-19 Vaccine

Back to: COVID-19 information for health professionals

Stay up-to-date

COVID-19 Vaccination Training Program

  • AstraZeneca Training Package 
  • For training modules from the Department of Health (National COVID-19 Vaccination Training Programclick here
  • For modules to consolidate and evaluate your technical skills, access education via Melbourne Vaccine Education Centre (Victorian COVID-19 eLearning Competency)here

Safety update

This section aims to include relevant safety updates as they relate to the COVID-19 vaccines.

To see all of the Australian Technical Advisory Group on Immunisation (ATAGI)'s updates, click here. 

Vaccine Rollout: Phase 1a

The COVID-19 vaccine rollout has begun across Australia.

The priority groups in this phase are:

  • Quarantine and border workers
  • Frontline health care worker sub-groups
  • Aged care and disability care staff
  • Aged care and disability residents

Use the eligibility checker to see find our when you or your patients can receive a COVID-19 vaccine. 

Residential Aged Care Facilities (RACFs)

On Monday 22 February, Residential Aged Care Facilities (RACF) began to receive vaccine supplies, starting the vaccination process for those in aged care.  

The Department of Health has published a readiness toolkit for residential aged care facilities to help prepare for the roll-out of COVID-19 vaccines and obtaining and recording consent for residents. Information about reporting adverse events will be available soon along with more resources for providers, workers and residents.

Providers have an important role in the COVID-19 vaccine program.

Facilities will need to:

  • provide information to residents and workers
  • facilitate resident consent
  • prepare their facility for vaccination day
  • monitor and report adverse events.

Disability rollout


Vaccine Rollout: Phase 1b

Update: 16 April 2021:

Information on indemnity, the rural and remote vaccine rollout, the delay in the delivery of vaccine consumables and seconds doses in residential aged care facilities. 
Access the document here.

Medical conditions covered under Phase 1b

Information for Aboriginal and Torres Strait Islander peoples

Vaccine rollout: Phase 2a

States and territories began vaccinating people in Phase 2a in May 2021 starting with all adults 50 years and over.

  • From 3 May 2021, people 50 years and over can receive the AstraZeneca vaccine at Commonwealth Vaccination and state and territory vaccination clinics.
  • From 17 May 2021, people 50 years and over can receive the AstraZeneca vaccine at a participating general practice.
  • From 28 May 2021 Victorians aged 40-49 years will be able to access the Pfizer vaccine at state-run vaccination sites, in line with advice from ATAGI. Read the Premier's statement. 
  • From 22 June 2021, the Australian Government introduced two new MBS items (10660 and 10661) to support General Practitioners and Other Medical Practitioners to provide in-depth clinical assessments of patients aged 50 years and over regarding patients’ individual health risks and benefits associated with receiving a COVID-19 vaccine. Further information: Item descriptors and Fact Sheet.

Vaccine rollout: Phase 2b

The Prime Minister announced that Cabinet agreed that from 30 August 2021, individuals aged between 16 and 39 years will be eligible for the Pfizer vaccine.

To simplify the transition of national eligibility to include those aged 16 to 39, practices that have capacity and available stock may book patients based on state and territory eligibility criteria. Phase 1 populations (such as aged and disability care staff, Aboriginal and Torres Strait islander people aged 12 and over, health care workers and those with an underlying health condition) should still be prioritised.


All general practices who have expressed an interest in administering the Pfizer vaccine have received notification of their commencement date and Pfizer allocation. If you have expressed your interest and have not received a letter, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. .Practices will be transitioned to Pfizer over a four-week period in September/October.

Influenza and COVID-19 Vaccination Advice

The Australian Technical Advisory Group on Immunisation (ATAGI) have provided advice on the relative timing of administering influenza and COVID-19 vaccines in 2021.

Key messages:

  • Routine scheduling and giving of an influenza vaccine with a COVID-19 vaccine on the same day is not recommended. 
  • The preferred minimum interval between a dose of seasonal influenza vaccine and a dose of Pfizer/BioNTech or AstraZeneca/University of Oxford is 14 days. 
  • There may be circumstances where co-administration or near administration (within days) of an influenza vaccine with a COVID-19 vaccine may be considered. 
  • There is no particular requirement regarding the order of receiving a dose of influenza vaccine and either the first or second dose of a COVID-19 vaccine. 
  • If an influenza vaccine has been inadvertently co-administered or given within a shorter interval than 14 days with a COVID-19 vaccine, revaccination with either vaccine is not considered necessary.

For further information, please download the publication here.

Community engagement resources

Looking for COVID vaccine resources to share with colleagues, consumers, family and friends?

Aboriginal and Torres Strait Islander People 

The Department of Health is coordinating the vaccine rollout for ACCHOS. Details can be found on their website:  

The Department has developed a suite of resources specifically for Aboriginal and Torres Strait Islander people.
These include an engagement kit, posters, suggested newsletter articles, social media posts and videos. These are updated as new information around dates, etc are confirmed. 

Back to top

Font Size A+ A= A-

Funding Opportunities

Tenders, Quotes & Expression of Interest Portal

If you’re interested in applying for funding opportunities, register your interest on SEMPHN's eProcure page. Once you register, you’ll receive information as it’s released.


Subscribe to latest updates from SEMPHN